Abstract
To compare the clinical, laboratory and immunological features of a group of Caucasian systemic lupus erythematosus (SLE) patients in relation to age at disease onset. Three groups of patients with different ages at disease onset were analysed and compared: group A (30 patients, ≥65 years); group B (62 patients, 50–64 years) and group C (163 patients, <50 years). All patients were regularly followed-up for a mean period of 6.5 years. Female predominance was reduced in groups A and B. Time-lapse between disease onset and diagnosis was longer in group A and B. There were no statistically significant differences in clinical features. The only relevant difference was observed in peripheral nervous system (PNS) involvement, more frequent in group A. Anti-dsDNA and RF were more frequent in group A. Complement levels were reduced more frequently in group C. No differences were observed in disease activity scores, while SLICC/ACR score was higher in group A. In Caucasian SLE patients, age at disease onset is not associated with differences in clinical features apart from a more frequent PNS involvement in elderly patients. In the same group, the organ damage seems to develop more rapidly mostly due to higher susceptibility to jatrogenic side effects.
Similar content being viewed by others
References
Hahn BH, Tsao BP (1997) Antibodies to DNA. In: Wallace DJ, Hahn BH (eds) Dubois’ lupus erythematosus. Williams and Wilkins, Baltimore, pp 407–422
Silman AJ (1993) Epidemiology and the rheumatic disease. In: Meddison PJ, Isenberg DA, Woo P et al (eds) Oxford textbook of rheumatology, 1st edn. Oxford University Press, Oxford, pp 499–513
Jonsson H, Nived O, Sturfelt G (1988) The effect of age on clinical and serological manifestations in unselected patients with systemic lupus erythematosus. J Rheumatol 15:505–509
Joseph RR, Zarafonetis CJD (1964) Clinical onset of lupus erythematosus in the older age group. J Am Geriatr Soc 12:787–799
Kammer GM, Mishra N (2000) Systemic lupus erythematosus in the elderly. Rheum Dis Clin North Am 26:475–492
Urowitz MB, Stevens MB, Shulman LE (1967) The influence of age on clinical pattern of systemic lupus erythematosus. Arthritis Rheum 10:319–320
Ward MM, Polisson RP (1989) A meta-analysis of the clinical manifestations of older onset systemic lupus erythematosus. Arthritis Rheum 32:1226–1232
Baker SB, Rovira JR, Campion EW, Mills JA (1979) Late onset systemic lupus erythematosus. Am J Med 66:727–732
Ballou SP, Khan MA, Kushner I (1982) Clinical features of systemic lupus erythematosus: differences related to race and age of onset. Arthritis Rheum 25:55–60
Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Domenech I, Aydintung AO, Jedryka-Goral A, de Ramon E et al (1993) Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on systemic lupus erythematosus. Medicine (Baltimore) 72:113–124
Costallat LT, Coimbra AM (1994) Systemic lupus erythematosus: clinical and laboratory aspect related to age at disease onset. Clin Exp Rheumatol 12:603–307
Domenech I, Aydintug O, Cervera R, Khamashta MA, Jedryka-Coral A, Vianna JL, Hughes GR (1992) Systemic lupus erythematosus in 50 year olds. Postgrad Med J 68:440–444
Font J Pallares L, Cervera R, Lopez-Sto A, Navarro M, Bosch X, Ingelmo M (1991) Systemic lupus erythematosus in the elderly: clinical and immunological characteristics. Ann Rheum Dis 50:702–705
Hashimoto H, Tsuda H, Hirano T, Takasaky Y, Matsumoto T, Hirose S (1987) Difference in clinical and immunological findings of systemic lupus erythematosus related to age. J Rheumatol 14:497–501
Ho CTK, Mok CC, Lau CS, Wong RW (1998) Late onset systemic lupus erythematosus in southern Chinese. Ann Rheum Dis 57:437–440
Koh ET, Boey ML (1994) Late onset lupus: a clinical and immunological study in a predominantly Chinese population. J Rheumatol 21:1463–1467
Catoggio LJ, Skinner RP, Smith G, Maddison PJ (1984) Systemic lupus erythematosus in the elderly: clinical and serological characteristics. J Rheumatol 11:175–181
Gaujard S, Broussoll C, Catherbras P, Cathebras P, Dupond JL, Massot C, Ninet J, Perrot H, Durand DV, Rousset H (2003) Systemic lupus erythematosus with disease onset at 65 and older. Rev Med Int 24:288–294
Hutton CW, Maddison PJ (1989) Systemic lupus erythematosus presenting as polymyalgia rheumatica in the elderly. Ann Rheum Dis 45:461–644
Mak S, Lam EJM, Wong AKM (1998) Clinical profile of patients with late-onset SLE: not a benign subgroup. Lupus 7:23–28
Maddison PJ (1987) Systemic lupus erythematosus in the elderly. J Rheumatol 14:182–187
Pu SJ, Luo SF, Wu YJJ, Cheng HS, Ho HH (2000) The clinical features and prognosis of lupus with disease onset at age 65 and older. Lupus 9:96–100
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725–1725
Alarcòn G, Williams G, Singer J, Steen V, Clegg D, Paulus H, Billingsley LM, Luggen ME, Polisson RP, Willkens RF et al (1991) Early undifferentiated connective tissue disease. I. Early clinical manifestation in a lare cohort of patients with undifferentiated connective tissue disease compared with cohort of well established connective tissue disease. J Rheumatol 18:1332–1339
Chisholm DM, Mason DK (1968) Labial salivary gland biopsy in Sjögren’s disease. J Clin Pathol 21:656–660
Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, Bacon P, Bombardieri S, Hanly E, Isenberg D, Jones J, Kalunian K, Maddison P et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369
Cooper GS, Dooley MA, Treadwell EL, StClair EW, Parks CG, Gilkeson GS (1998) Hormonal, environmental and infectious risk farctors for developing systemic lupus erythematosus. Arthritis Rheum 41:1714–1724
Foad BSI, Sheon RP, Kirsner AB (1972) Systemic lupus erythematosus in the elderly. Arch Intern Med 130:743–746
Hess EV (1999) Lupus: the clinical entity. In: Kammer GM, Tsokos GC (eds) Lupus: molecular and cellular pathogenesis. Humana Press, Totowa, pp 1–12
Maddison P, Farewell V, Isenberg D, Aranow C, Bae SC, Barr S, Buyon J, Fortin P, Ginzler E, Gladman D, Hanly J, Manzi S, Nived O, Petri M, Ramsay-Goldman R, Sturfelt G (2002) The rate and pattern of organ damage in late onset systemic lupus erythematosus. J Rheumatol 29:913–917
Hochberg MC, Boyd RE, Ahearn JM, Arnett C, Bias WB, Provost TT, Stevens MB (1985) Systemic lupus erythematosus. A review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subset. Medicine 64:285–295
Jacobsen S, Petersen J, Ullman S, Junker P, Voss A, Rasmussen JM, Tarp U, Poulsen L, van Overeen Hansen G, Saarup B, Hansen TM, Podenphant J, halberg P (1998) A multicentre study of 513 Danish patients with systemic lupus erythematosus. Disease manifestations and analyses of clinical subsets. Clin Rheumatol 17:468–477
Lee SS, Li CS, Li PC (1993) Clinical profile of Chinese patients with systemic lupus erythematosus. Lupus 2:105–109
Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Mejia JC, Aydintung AO, Chwalinska-Sadowska H, de Ramon E, Fernandez-Nebro A et al (2003) European Working Party on Systemic Lupus Erythematosus. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 82:299–308
Wilson HA, Hamilton ME, Spyker DA, Brunner CM, o’Brien WM, Davis JS 4th, Winfield JB (1981) Age influences the clinical and serologic expression of systemic lupus erythematosus. Arthritis Rheum 24:1230–1235
Bajocchi G, La Corte R, Locaputo A, Govoni M, Trotta F (2000) Elderly onset rheumatoid arthritis: clinical aspects. Clin Exp Rheumatol 18:549–550
Govoni M, Bajocchi G, Rizzo N, Tola MR, Caniatti L, Tugnoli V, Colamuss P, Trotta F (1999) Neurological involvement in Primary Sjogren’s syndrome: clinical and instrumental evaluation in a cohort of Italian patients. Clin Rheum 18:299–303
Fields RA, Toubbeh H, Searles RP, Bankhurst AD (1989) The prevalence of anticardiolipin antibodies in a healthy population and its association with antinuclear antibodies. J Rheumatol 16:623–625
Goodwin JS, Searles RP, Tung SK et al (1982) Immunological responses of healthy elderly population. Clin Exp Immunol 48:403–410
Ruffatti A, Calligaro A, Del Ross T, Lagni M, Marson P, Todesco S (1990) Anti-double-stranged DNA antibodies in the healthy elderly. Prevalence and characteristics. J Clin Immunol 10:300–303
Juby AG, Davis P, McElhaney JE, Gravenstein S (1994) Prevalence of selected autoantibodies in different elderly subpopulations. Br J Rheumatol 33:1121–1124
Effros RB, Boucher N, Porter V, Zhu X, Spoulding C, Walfird RL, Kronenberg M, Cohen D, Schachter F (1994) Decline in CD28+ T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence. Exp Gerontol 29:601–609
Boucher N, Defeu-Duchesne T, Vicaut E, Farge D, Effros RB, Schachter F (1998) CD28 expression in T cell aging and human longevity. Exp Gerontol 33:267–282
Whisler RL, Beiqing L, Chen M (1996) Age-related decrease in IL-2 production by human T cells are associated with impaired activation of nucleare transcription factors AP-1 and NF-AT. Cell Immunol 169:185–195
Caruso C, Candore G, Cigna D, Dilorenzo G, Sireci G, Dieli F, Salerno A (1996) Cytokine production pathway in the elderly. Immun Res 15:84–90
Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) The development and validation of the SLE Disease Activity Index (SLEDAI). Arthritis Rheum 35:630–640
Formiga F, Moga I, Pac M, Mitjavila F, Rivera A, Pujol R (1999) Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI. SLE Disease Activity Index. Lupus 8:462–465
Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Scinto M, Bombardieri S (1992) Disease activity in systemic lupus erythematosus: report of the consensus study group of the European Workshop for Rheumatology Research. The European Consensus Study Group for the disease activity in SLE. Clin Exp Rheumatol 10:541–547
Bertoli A, Alarcòn G, Calvo-Alèn J, Fernández M, Vilá L, Reveille J. (2006) Systemic lupus erthematosus in a multiethnic US cohort. Clinical features, course and outcome in patients with late-onset disease. Arthritis Rheum 54:1580–1587
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Padovan, M., Govoni, M., Castellino, G. et al. Late onset systemic lupus erythematosus: no substantial differences using different cut-off ages. Rheumatol Int 27, 735–741 (2007). https://doi.org/10.1007/s00296-006-0284-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-006-0284-3